NRF2 Signaling: A Keystone in Inflammation and Disease Management

Nuclear Factor Erythroid 2–Related Factor 2 (NRF2) orchestrates a principal defense mechanism against oxidative stress and plays a pivotal role in inflammation and disease pathogenesis. This article explores the mechanism of NRF2 signaling, its intricate relationship with inflammation, its implications in various diseases, and the therapeutic potential of NRF2 modulation.

Understanding NRF2 Signaling

Basic Mechanism of Action

NRF2 is a transcription factor that, upon activation, migrates to the nucleus to bind to Antioxidant Response Elements (ARE) in the DNA, promoting the expression of genes involved in antioxidant defense, detoxification, and cellular homeostasis.

Regulation by KEAP1

Under basal conditions, NRF2 is bound by KEAP1, which targets it for ubiquitination and subsequent degradation. Oxidative stress or electrophilic agents disrupt this interaction, stabilizing NRF2 and allowing it to activate its target genes.

NRF2 in Inflammation Control

Anti-inflammatory Mechanisms

NRF2 mitigates inflammation by upregulating antioxidants and downregulating pro-inflammatory cytokines, thereby reducing oxidative stress and inflammation.

Cross-talk with NF-κB

NRF2 and NF-κB signaling pathways interact closely, with NRF2 activation generally inhibiting NF-κB, thus attenuating inflammation.

Implications of NRF2 Dysregulation in Diseases

Cancer

NRF2 plays a dual role in cancer, providing cytoprotection that can prevent cancer initiation but also potentially contributing to cancer progression and resistance to therapy when aberrantly activated.

Neurodegenerative Diseases

Reduced NRF2 activity is associated with increased oxidative stress and neuronal damage in diseases like Alzheimer's and Parkinson's, suggesting NRF2 activation as a therapeutic strategy.

Chronic Inflammatory Diseases

In conditions such as rheumatoid arthritis and inflammatory bowel disease, NRF2 dysregulation exacerbates inflammation, pointing to NRF2 modulation as a potential therapeutic approach.

Therapeutic Potential of NRF2 Modulation

NRF2 Activators

Compounds like sulforaphane activate NRF2, offering protection against oxidative stress and inflammation, with implications for treating neurodegenerative and inflammatory diseases.

NRF2 Inhibitors

In the context of cancer, where NRF2 may promote tumor survival, NRF2 inhibitors are being explored as a therapeutic strategy.

Summarizing Table: NRF2 Signaling in Disease Contexts

Disease Type	Role of NRF2	Potential Therapeutic Approach
Cancer	Dual role: protective and potentially promotive	NRF2 inhibitors in NRF2-driven cancers
Neurodegenerative Diseases	Reduces oxidative stress and neuronal damage	NRF2 activators
Chronic Inflammatory Diseases	Attenuates inflammation	NRF2 activators

Conclusion

NRF2 signaling stands at the crossroads of inflammation and disease, offering a potent target for therapeutic intervention. Understanding the nuanced roles of NRF2 in various disease contexts is essential for developing targeted therapies that modulate this pathway for optimal patient outcomes. Continued research into NRF2 signaling will undoubtedly unlock new avenues for the treatment of oxidative stress-related diseases, heralding a new era in precision medicine.

References

Kensler, T.W., Wakabayashi, N., & Biswal, S. (2007). Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annual Review of Pharmacology and Toxicology, 47, 89-116. https://doi.org/10.1146/annurev.pharmtox.46.120604.141046

Taguchi, K., Motohashi, H., & Yamamoto, M. (2011). Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution. Genes to Cells, 16(2), 123-140. https://doi.org/10.1111/j.1365-2443.2010.01473.x

Cuadrado, A., Rojo, A.I., Wells, G., Hayes, J.D., Cousin, S.P., Rumsey, W.L., ... & Dinkova-Kostova, A.T. (2019). Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. Nature Reviews Drug Discovery, 18(4), 295-317. https://doi.org/10.1038/s41573-018-0008-x

Zhang, D.D. (2006). Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metabolism Reviews, 38(4), 769-789. https://doi.org/10.1080/03602530600971974

Baird, L., & Dinkova-Kostova, A.T. (2011). The cytoprotective role of the Keap1-Nrf2 pathway. Archives of Toxicology, 85(4), 241-272. https://doi.org/10.1007/s00204-011-0674-5

Ma, Q. (2013). Role of nrf2 in oxidative stress and toxicity. Annual Review of Pharmacology and Toxicology, 53, 401-426. https://doi.org/10.1146/annurev-pharmtox-011112-140320

Rushmore, T.H., & Kong, A.N. (2002). Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes. Current Drug Metabolism, 3(5), 481-490. https://doi.org/10.2174/1389200023337054

Lee, J.M., Johnson, J.A. (2004). An important role of Nrf2-ARE pathway in the cellular defense mechanism. Journal of Biochemistry and Molecular Biology, 37(2), 139-143. https://doi.org/10.5483/BMBRep.2004.37.2.139

Written by Zainab Riaz

Zainab Riaz completed her Master degree in Zoology from Fatimah Jinnah University in Pakistan and is currently pursuing a Doctor of Philosophy in Zoology at University of Lahore in Pakistan.